Isis Pharmaceuticals Inc. (ISIS) Chairman, President, CEO Stanley T Crooke sells 32,000 Shares

Chairman, President, CEO of Isis Pharmaceuticals Inc. (ISIS, Financial) Stanley T Crooke sells 32,000 shares of ISIS on 12/29/2010 at an average price of $10.38 a share.

Isis Pharmaceuticals Inc. has a market cap of $1.02 billion; its shares were traded at around $10.32 with and P/S ratio of 8.5.

ISIS is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Jim Simons of Renaissance Technologies LLC, Jean-Marie Eveillard of First Eagle Investment Management, LLC.

CEO Recent Trades:

  • Sell: Chairman, President, CEO Stanley T Crooke sold 20,000 shares of ISIS stock on 12/23/2010 at the average price of 10.52. Stanley T Crooke owns at least 875,391 shares after this. The price of the stock has decreased by 1.9% since.



Directors and Officers Recent Trades:

  • Sell: COO B Lynne Parshall sold 6,450 shares of ISIS stock on 12/23/2010 at the average price of 10.52. B Lynne Parshall owns at least 1,985 shares after this. The price of the stock has decreased by 1.9% since.

  • Sell: Senior Vice President Richard S Geary sold 3,000 shares of ISIS stock on 12/23/2010 at the average price of 10.52. Richard S Geary owns at least 1,579 shares after this. The price of the stock has decreased by 1.9% since.

  • Sell: Senior Vice President C Frank Bennett sold 7,700 shares of ISIS stock on 12/23/2010 at the average price of 10.52. C Frank Bennett owns at least 561 shares after this. The price of the stock has decreased by 1.9% since.

  • Sell: Senior Vice President Richard S Geary sold 200 shares of ISIS stock on 12/23/2010 at the average price of 10.53. Richard S Geary owns at least 1,579 shares after this. The price of the stock has decreased by 1.99% since.

  • Sell: Senior Vice President C Frank Bennett sold 1,100 shares of ISIS stock on 07/23/2010 at the average price of 9.6. C Frank Bennett owns at least 561 shares after this. The price of the stock has increased by 7.5% since.